SCHEMBL17482005

SCHEMBL17482005

Cc1ccc2c(c1)c1cc(Cl)ccc1n2CC(O)CO

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAD52 P43351 1/20 0.56
NLRP1 Q9C000 1/20 0.56
LMNA P02545 4/20 0.55
ALDH1A1 P00352 2/20 0.55
HTT P42858 4/20 0.46
NPSR1 Q6W5P4 2/20 0.46
HSP90AA1 P07900 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
MAPT P10636 3/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
TP53 P04637 1/20 0.46
KDM4E B2RXH2 2/20 0.45
DNM1 Q05193 2/20 0.43
ALOX15 P16050 2/20 0.43
HSD17B10 Q99714 2/20 0.43
THRB P10828 1/20 0.43
GRIN2D O15399 1/20 0.42
GRIN3B O60391 1/20 0.42
GRIN1 Q05586 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14706715 0.91 RAD52 (0.64) RAD52NLRP1LMNAALDH1A1HTT
SCHEMBL17484540 0.91 HSD17B10 (0.49) LMNANPSR1SMN1; SMN2MAPTMEN1
SCHEMBL16604024 0.83 RAD52 (0.74) RAD52NLRP1LMNAALDH1A1HTT
SCHEMBL407111 0.79 DNM1 (0.55) RAD52NLRP1LMNAALDH1A1NPSR1
SCHEMBL15880984 0.77 DNM1 (0.69) RAD52NLRP1LMNAALDH1A1HTT
SCHEMBL21093184 0.76 RAD52 (0.54) RAD52NLRP1LMNAALDH1A1HTT
SCHEMBL15489554 0.75 HSD17B10 (0.45) LMNAALDH1A1NPSR1SMN1; SMN2MAPT
SCHEMBL16923669 0.75 DNM1 (0.67) RAD52LMNAALDH1A1HTTNPSR1
SCHEMBL6823233 0.75 RAD52 (0.86) RAD52NLRP1LMNAALDH1A1HTT
SCHEMBL28586701 0.74 TSHR (0.65) RAD52NLRP1LMNAALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9862684-B2 Modulation of K2P channels THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2018-01-09 US disclosed
US-20160031814-A1 MODULATION OF K2P CHANNELS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160031814-A1 MODULATION OF K2P CHANNELS KCNJ2, KCNK2, KCNN3 RAD52 4575/4885NLRP1 1337/4885LMNA 2035/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.